is consider [10%:500 mcg/dL) (Perrone 2015). The IM route may be used (per the manufacturer) but is not preferred and rarely indicated. The use of deferoxamine in situations in which the peak serum iron concentration is] Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Deferoxamine Rating No Reviews - Be the first! No Reviews - Be the first! Not Rated - Be the first! Manufacturers Pfizer Inc. Pliva Fresenius Kabi USA, LLC Drug Class Antidotes Chelating agents Related Drugs antidotes naltrexone , atropine , naloxone , acetylcysteine , leucovorin chelating agents Jadenu , Exjade , deferasirox , trientine , Desferal , Ferriprox Iron Poisoning, Acute Desferal , More... Iron Poisoning, Chronic Desferal , More... a really
well-merited Deferoxamine recognized
EmoticonEmoticon